GPC1 and pancreatic neoplasm: Studies have shown that GPC-1, an exosome membrane protein, can be chooses to differentiate pancreatic cancer patients from chronic pancreatitis patients and healthy people with specificity and sensitivity up to 100% (31).All the above results indicate that exosomes are expected to become a new type of biomarker.